may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
.
.
.
.
he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.